The industrial synthesis of high-purity pharmaceutical intermediates stands as a cornerstone for reliable active pharmaceutical ingredient (API) production. Achieving 99.5 percent purity, particularly for advanced intermediates like PER (CAS 123456-78-9, molecular weight 326.41, molecular formula C15H14F3N3O2), is not only a mark of technical precision but also a defining element in downstream application success. The stereochemistry of this intermediate plays an essential role in conferring the desired activity and selectivity in API synthesis, with the control of chiral centers and functional groups being vital for regulatory and therapeutic acceptance. Technical Insights specializes in delivering such advanced intermediates, leveraging a robust cGMP framework and validated production protocols to ensure consistent quality, regulatory compliance, and secure supply to pharmaceutical manufacturers globally.
In the context of API development, the PER intermediate, with its distinctly controlled configuration, provides a critical building block for complex syntheses. The relevance of stereochemistry in this molecule, particularly the maintenance of the (S)-configuration at its amide center, is maintained meticulously throughout the production process. Technical Insights is recognized for its capacity to deliver not just quantity but also documentary and batch-level assurance, supporting customers at every stage from R&D to commercial launch.
Batch manufacturing of 99.5 percent purity PER involves a series of carefully optimized steps, each defined by specific reaction conditions. The industrial process commences with the reaction between 4-fluorobenzylamine and ethyl 3-oxo-3-(trifluoromethyl)propanoate in anhydrous acetonitrile as the solvent. The mixture is stirred at a controlled temperature of 0 to 5°C for four hours under a nitrogen atmosphere, ensuring that side reactions are minimized and thermal degradation is avoided. Upon completion of the initial condensation, the mixture undergoes gradual pH adjustment via slow addition of aqueous sodium carbonate to achieve a pH of 8.2. This step is essential to initiate selective crystallization of the desired intermediate.
Crystallization takes place by allowing the mixture to stand at 10°C for 12 hours, promoting the formation of pure PER crystals while impurities remain soluble. The isolated solid is subjected to two sequential washes using pre-chilled isopropanol and ultrapure water, enhancing removal of byproducts and unreacted starting material. Typical yields for this process reach 92 percent, with HPLC purity consistently at or above the 99.5 percent benchmark. Nuclear magnetic resonance analysis provides unimpeachable identity confirmation, with the 1H NMR spectrum (400 MHz, DMSO-d6) displaying characteristic signals: δ 7.52 (d, J = 8.8 Hz, 2H), 7.29–7.24 (m, 2H), 6.85 (s, 1H), 4.62 (s, 2H), 3.12 (t, J = 7.2 Hz, 2H), and 2.04 (s, 3H), corresponding to the aromatic and aliphatic protons in the structure.
Ensuring cGMP compliance is a multi-layered commitment in the manufacture of 99.5 percent pure PER. The certificate of analysis for each batch comprises a thorough set of analytical characterizations. Confirmatory 1H NMR and FT-IR spectra establish identity and functional group integrity, while HPLC is employed for quantitative purity assessment. Gas chromatography testing adheres rigorously to ICH Q3C guidelines for residual solvents, ensuring that all traces of class I and II solvents remain well below regulatory thresholds. Moreover, inductively coupled plasma mass spectrometry (ICP-MS) is performed in accordance with ICH Q3D to monitor for elemental impurities such as Pb, Cd, As, and Hg, ensuring heavy metal content remains negligible. Water content is determined by Karl Fischer titration, guaranteeing suitability for moisture-sensitive processes. Technical Insights further supports its client base with a comprehensive drug master file (DMF), providing regulatory authorities and partners with detailed chemistry, manufacturing, and control (CMC) data as required for global submissions.
The isolation and crystallization strategy are pivotal for achieving market-leading levels of product purity. Following initial crystallization, the solid intermediate undergoes a multi-stage wash protocol. First, a wash with ice-cold isopropanol efficiently strips away organic byproducts, while a subsequent rinse with deionized water removes inorganic residues and soluble salts. These steps are conducted under an inert nitrogen blanket to prevent atmospheric moisture uptake. The washed crystals are then subjected to vacuum drying at 40°C under a pressure of 20 mbar for 24 hours—conditions established through process validation as optimal for achieving both efficient drying and maximal stability, with no measurable degradation observed. For more details and batch availability, readers can refer to the dedicated product page.
From a technical standpoint, PER demonstrates a well-defined suite of physicochemical properties. Its appearance is described as a white crystalline solid. The purity, as determined by HPLC, is maintained at or above 99.5 percent, and typical batch yield registers at 92 percent. Moisture content, measured by Karl Fischer titration, consistently measures below 0.3 percent. Residual solvents, as identified by GC in line with ICH Q3C guidelines, are maintained at undetectable levels. Heavy metals are present below 1 ppm as confirmed by ICP-MS. The melting point ranges from 118 to 121°C, and each batch is accompanied by a certificate of analysis documenting these parameters.
In summary, the industrial production of PER at 99.5 percent purity for pharmaceutical intermediate applications exemplifies best practices in modern, cGMP-compliant manufacturing. Through rigorous process validation, detailed analytical characterization, and continuous quality improvement, Technical Insights provides a secure, regulatory-ready supply of this key intermediate to the pharmaceutical sector. Whether destined for early-stage process development or commercial API synthesis, clients can count on both the chemistry and the documentation to meet stringent global standards.
Related Articles
